• Mdivi-1 in ER Stress–NLRP3 Pathway Studies

  2026-08-15

  Mdivi-1 is a selective DRP1 inhibitor for dissecting mitochondrial fission, apoptosis, and inflammatory signaling. This guide applies the compound to ER stress–NLRP3 research and translates a pulmonary dysfunction study into practical assay-design decisions.

• MLN4924 Workflow for NEDD8 Pathway Studies

  2026-08-14

  MLN4924 provides a selective way to connect NAE inhibition with cullin-RING ligase activity, substrate stabilization, cell-cycle disruption, and cancer phenotypes. This workflow combines proximal pathway readouts with lessons from a time-resolved Nrf2 and rotavirus study to improve assay interpretation without overstating cross-domain evidence.

• AICAR Phosphate: AMPK Assay Workflows

  2026-08-14

  AICAR phosphate (Acadesine) provides a practical chemical perturbation tool for connecting AMPK signaling with apoptosis, especially in B-cell chronic lymphocytic leukemia research. This guide translates its concentration, handling, and mechanistic profile into reproducible cell-based workflows while showing how the reference study can inform exploratory hypoxia and barrier assays.

• Dye Models for Small Biopsy Pathology

  2026-08-13

  The reference study evaluates five dyes as pre-processing markers for very small biopsy specimens and shows that merbromin, hematoxylin, and Alcian blue improve tissue visibility during routine preparation. Its practical contribution is to separate visibility enhancement from downstream diagnostic compatibility, leading the authors to favor hematoxylin for routine use.

• Bay 11-7085: NF-κB Activation Workflow

  2026-08-13

  Bay 11-7085 is a practical NF-κB activation inhibitor for connecting inflammatory signaling with proliferation and apoptosis readouts. This guide translates ER-stress findings after subarachnoid hemorrhage into reproducible cell-assay workflows, with application-specific controls and troubleshooting.

• Tyrothricin Workflows for Membrane Disruption Research

  2026-08-12

  Build reproducible bacterial and fungal assays around Tyrothricin, a membrane-active peptide antibiotic mixture, with practical dose-ranging, time-kill, and orthogonal readout strategies. The workflow also adapts the reference study’s time-resolved resistance logic without confusing oncology findings with direct antimicrobial evidence.

• Halazone for Reliable Laboratory Workflows

  2026-08-12

  This scenario-based guide explains how Halazone (SKU BA1377) can support controlled water disinfection and mechanistic neurophysiology workflows while highlighting compatibility limits in live-cell viability assays. It provides evidence-linked concentration, handling, interpretation, and vendor-selection guidance for reproducible laboratory decision-making.

• Dabigatran etexilate Bench Workflows

  2026-08-11

  Build reproducible thrombin, plasma-clotting, and translational anticoagulation assays with Dabigatran etexilate. This guide connects its prodrug biology and nanomolar potency to practical stock preparation, endpoint selection, troubleshooting, and atrial fibrillation research workflows.

• AR Heterogeneity in Prostate Cancer Therapy Response

  2026-08-10

  Li and colleagues show that androgen receptor heterogeneity is functionally linked to distinct castration-resistant prostate cancer behaviors and responses to enzalutamide. By combining patient samples, engineered LNCaP models, xenografts, RNA sequencing, and combination therapy, the study identifies BCL-2 as a potential vulnerability in both AR-high and AR-low disease states.

• Recombinant Human IL-15: From Assay to Insight

  2026-08-09

  Recombinant Human IL-15 supports controlled T cell activation, Natural killer cell proliferation, and quantitative cytokine assays. This article connects rigorous IL-15 workflow design with a critical reading of recent oxytocin-based neurobehavioral research while clearly separating evidence from hypothesis.

• CP-673451: Selective PDGFRα/β Inhibitor Workflows

  2026-08-08

  CP-673451 enables focused interrogation of PDGFR signaling, PDGF-BB-driven angiogenesis, and tumor biology with less off-target kinase interference than broad RTK inhibitors. This guide translates its biochemical and cellular profile into reproducible assays, ATRX-aware glioma experiments, xenograft study design, and practical troubleshooting.

• Wnt-Driven O-GlcNAcylation in Bone Formation

  2026-08-07

  The reference study identifies O-GlcNAcylation as a metabolic and post-translational relay through which Wnt3a promotes osteoblastogenesis, bone formation, and fracture healing. Its central mechanistic insight is that Wnt3a stabilizes PDK1 through modification at Ser174, thereby increasing aerobic glycolysis and coupling glucose metabolism to bone anabolism.

• GCL Homolog Controls Early Spermatogenesis in Macrobrachium

  2026-08-07

  This study identifies and characterizes a germ cell-less (GCL) homolog in the giant prawn, Macrobrachium rosenbergii, illuminating its essential role in early spermatogenesis. Insights from RNAi knockdown experiments reveal that MroGCL is crucial for mitotic progression and sperm yield, with implications for crustacean reproductive biology and sterile population management.

• Ion Supplementation Enhances CPP-Mediated Nucleic Acid Deliv

  2026-08-06

  This study reveals how adding specific inorganic ions during the preparation of cell-penetrating peptide (CPP)/nucleic acid (NA) nanoparticles significantly improves delivery efficiency. The findings offer mechanistic insight into how ions modulate nanoparticle properties and inform optimization strategies for non-viral gene delivery systems.

• PR-619 in Disease Modeling: Unlocking DUB Inhibition in Canc

  2026-08-06

  Explore PR-619 as a deubiquitylating enzymes inhibitor for advanced disease modeling. This article uniquely examines PR-619's role in bridging cancer and neurodegenerative research, offering new technical insights for assay design.

453 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page